Publication | Closed Access

Combined Use of Anticancer Drugs and an Inhibitor of Multiple Drug Resistance-Associated Protein-1 Increases Sensitivity and Decreases Survival of Glioblastoma Multiforme Cells In Vitro

Neuro-oncologyGliomaMedicineCancer GrowthImmune Checkpoint InhibitorAnti-cancer AgentHigh-grade GliomasGlioblastoma Multiforme CellsAnticancer DrugsCancer TreatmentPharmacologyCell BiologyTumor MicroenvironmentDecreases Survival